United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Laurus Bio secures Rs 160cr investment to accelerate expansion Laurus Bio Private Limited, a subsidiary of Laurus Labs, has announced a significant equity investment totalling ₹160 crore.… byPallavi MadhirajuDecember 6, 2024